Lung Neoplasms

Showing 1 - 25 of 277

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Protein Kinase Inhibitors, Other Protocol Specified Criteria, Lung Tumors Trial in Guangzhou (JYP0322)

Recruiting
  • Protein Kinase Inhibitors
  • +3 more
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Nov 9, 2023

MDSCs and Cancer Stem Cells and Their Cross Talks in NSCLC

Not yet recruiting
  • Lung Neoplasms
  • +2 more
  • Tumor samples
  • Bordeaux, France
    CHU de Bordeaux - Hôpital Saint-André, Service d'Oncologie Médic
Aug 28, 2023

Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

Not yet recruiting
  • Lung Cancer
  • +8 more
  • Ion Endoluminal System
  • Orlando, Florida
  • +2 more
Aug 16, 2023

Tumors, Prostatic Tumors, Castration-Resistant, Stomach Tumors Trial in United Kingdom (HTL0039732 Capsules, HTL0039732 Capsules

Recruiting
  • Neoplasms
  • +13 more
  • HTL0039732 Capsules
  • HTL0039732 Capsules and atezolizumab infusion
  • Cambridge, United Kingdom
  • +4 more
Jul 5, 2023

Lung Tumors Trial (Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy), Envafolimab combined

Not yet recruiting
  • Lung Neoplasms
  • Envafolimab combined with concurrent chemoradiotherapy (Hypofractionated radiotherapy)
  • Envafolimab combined with concurrent chemoradiotherapy (Conventional Radiotherapy)
  • (no location specified)
Jun 12, 2023

Lung Tumors Trial (Active Cycle of Breathing Techniques)

Not yet recruiting
  • Lung Neoplasms
  • Active Cycle of Breathing Techniques
  • (no location specified)
May 25, 2023

Lung Tumors Trial (Lidocaine, Saline)

Not yet recruiting
  • Lung Neoplasms
  • (no location specified)
May 6, 2023

Delirium, Aged, Lung Tumors Trial (Acetaminophen and Ibuprofen, Normal saline)

Not yet recruiting
  • Delirium
  • +4 more
  • Acetaminophen and Ibuprofen
  • Normal saline
  • (no location specified)
Apr 17, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Lung Tumors, PET-CT Specimen Imager Trial in Ghent (AURA10 Specimen Imager)

Not yet recruiting
  • Lung Neoplasms
  • PET-CT Specimen Imager
  • AURA10 Specimen Imager
  • Ghent, Belgium
    University Hospital Ghent
Jan 11, 2023

Lung Tumors, Pneumothorax Trial (HFNO)

Not yet recruiting
  • Lung Neoplasms
  • Pneumothorax
  • HFNO
  • (no location specified)
Dec 23, 2022

Lung Tumors Trial in Altoona, Philadelphia (nCLE aided RANB biospy)

Recruiting
  • Lung Neoplasms
  • nCLE aided RANB biospy
  • Altoona, Pennsylvania
  • +1 more
Dec 27, 2022

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Specimen Banking From Patients With Lung Cancer

Recruiting
  • Lung Neoplasms
    • Aurora, Colorado
      University of Colorado Cancer Center
    Dec 13, 2022

    Hydroxychloroquine, Gemcitabine, Lung Tumors Trial (Hydroxychloroquine Combined With Gemcitabine)

    Not yet recruiting
    • Hydroxychloroquine
    • +2 more
    • Hydroxychloroquine Combined With Gemcitabine
    • (no location specified)
    Dec 3, 2022

    Oncogenes and Resistance Mechanisms in Lung Cancer

    Recruiting
    • Lung Neoplasms
      • Aurora, Colorado
        University of Colorado Cancer Center
      Oct 31, 2022

      Tumors, Lung Tumors Trial in St Leonards (MLC Tracking)

      Active, not recruiting
      • Neoplasms
      • Lung Neoplasms
      • MLC Tracking
      • St Leonards, New South Wales, Australia
        Royal North Shore Hospital
      Oct 25, 2022

      NSCLC, Lung Diseases, Lung Tumors Trial in New Haven (Sitravatinib, Pembrolizumab)

      Recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +8 more
      • New Haven, Connecticut
        Yale University
      Oct 26, 2022

      Related to Chronic Cough After Pulmonary Resection

      Recruiting
      • Persistent Cough
      • +2 more
        • Guangzhou, Guangdong, China
          Guangdong Provincial People's Hospital
        Oct 16, 2022

        Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)

        Completed
        • Lung Adenocarcinoma
        • Lung Neoplasms
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Oct 17, 2022

        Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

        Recruiting
        • Lung Neoplasms
        • +23 more
        • La Jolla, California
        • +35 more
        Oct 6, 2022

        Solitary Pulmonary Nodule, Coin Lesion, Pulmonary, Lung Tumors Trial in Pasadena (More Frequent Surveillance Strategy, Less

        Active, not recruiting
        • Solitary Pulmonary Nodule
        • +3 more
        • More Frequent Surveillance Strategy
        • Less Frequent Surveillance Strategy
        • Pasadena, California
          Kaiser Permanente Southern California
        Sep 30, 2022

        Progression of Invasive Squamous Cell Carcinoma

        Recruiting
        • Carcinoma, Squamous Cell
        • +10 more
        • DNA Extraction
        • Rochester, Minnesota
          Mayo Clinic in Rochester
        Sep 27, 2022

        Circulating Tumor Cells (CTC) in Lung Cancer

        Recruiting
        • Lung Neoplasms
        • Blood draw
        • Indianapolis, Indiana
        • +1 more
        Sep 23, 2022